ACT EXEMESTANE
As listed in the register: ACT EXEMESTANE
25 mg · tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Exemestane
- Made by
- Teva Canada Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (EXEMESTANE). It describes the substance, not this exact product.
Breast cancer cell growth may be estrogen-dependent.
Aromatase is the principal enzyme that converts androgens to estrogens both in pre- and postmenopausal women.
Exemestane is extensively metabolized, with levels of the unchanged drug in plasma accounting for less than 10% of the total radioactivity.
Following administration of radiolabeled exemestane to healthy postmenopausal women, the cumulative amounts of radioactivity excreted in urine and feces were similar (42 ± 3% in urine and 42 ± 6% in feces over a 1-week collection period).
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-24
Safety of the active substance
From the US prescribing label for the same active substance (EXEMESTANE). It describes the substance, not this exact product.
- EXEMESTANE is contraindicated in patients with a known hypersensitivity to the drug or to any of the excipients.
- Patients with a known hypersensitivity to the drug or to any of the excipients ( 4 ).
Most common adverse reactions were mild to moderate and included hot flushes (13% vs. 5%), nausea (9% vs. 5%), fatigue (8% vs. 10%), increased sweating (4% vs. 8%), and increased appetite (3% vs. 6%) for EXEMESTANE and megestrol acetate, respectively ( 6, 6.1 ).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States11 matching products
Spain24 matching products
- AROMASIL 25 mg exemestano · comprimido recubierto8 makers
- EXEMESTANO ACCORD 25 MG · comprimido recubierto con película
- EXEMESTANO AUROVITAS 25 mg · comprimido recubierto con película
- EXEMESTANO AUROVITAS SPAIN 25 mg exemestano · comprimido recubierto con película
- EXEMESTANO CINFA 25 mg · comprimido recubierto con película
- EXEMESTANO DESGEN 25 mg · comprimido recubierto con película
- EXEMESTANO FARMALIDER 25 mg · comprimido recubierto con película
- EXEMESTANO KERN PHARMA 25 mg · comprimido recubierto con película
Netherlands10 matching products
- Aromasin omhulde tabletten 25 mg 25 mg · omhulde tablet
- Exemestaan 25 mg Teva 25 mg · filmomhulde tablet
- Exemestaan Accord 25 mg 25 mg · filmomhulde tablet
- Exemestaan Devatis 25 mg filmomhulde tabletten 25 mg · filmomhulde tablet
- Exemestaan Hikma 25 mg 25 mg · filmomhulde tablet
- Exemestaan Pfizer 25 mg · omhulde tablet
- Exemestaan Sandoz 25 mg 25 mg · filmomhulde tablet
- Exemestaan Synthon 25 mg 25 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Teva Canada Limited |
|---|---|
| Active substance | Exemestane |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 25 mg |
| Form | tablet |
| Classification | L02BG06 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02390183 |
| DPD drug code | 87564 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.